What labeling requirements and performance factors matter for pharmaceutical packaging?

Pharmaceutical packaging labels need to meet the current Drugs and Cosmetics Act and Rules and any other requirements that apply to the specific medicine, pack format, and market. Performance considerations can include legibility, adhesion, cold-chain or moisture resistance where relevant, sufficient space for required information, tamper evidence when specified, and serialised or variable data where a track-and-trace programme requires it.

Required label content can include the drug name, manufacturer and licence details, batch information, manufacturing and expiry dates, storage conditions, dosage or warning statements, and other schedule-specific declarations. The exact content differs by drug category and should be reviewed by regulatory affairs. GMP requirements affect packaging control and product integrity, but a specific VOID, destructible, or honeycomb seal should not be described as universally mandatory unless the applicable regulation or product specification requires it.

Content space is often a practical challenge because pharmaceutical packs can be small while required information is extensive, making multilayer or booklet labels useful in some applications. For export drug formulations from India, DGFT track-and-trace and barcode requirements may apply at defined packaging levels, commonly using GS1 standards. Domestic, export, and destination-market rules can differ, so all pharmaceutical artwork and security features should be verified against current product-specific requirements before printing.